allergy-diagnostics-therapeutics-market

Allergy Diagnostics And Therapeutics Market Size, Share & Trends
Analysis Report and Segment Forecast, 2022 | Grand View Research, Inc
“Increasing
incidences of allergic diseases coupled with demand for in vitro
diagnostic blood test is posed to drive the Allergy Diagnostics And
Therapeutics industry growth in coming years. ”
Global Allergy Diagnostics And Therapeutics Market is expected to reach USD 40.8 billion by 2022, according to a
new report by Grand View Research, Inc. Increasing prevalence of allergic conditions and adoption of immunoassay
as a viable diagnostic test is expected to serve this market with lucrative future growth opportunities.
The prevalence of target diseases such as asthma and food allergies are expected to grow over the next seven
years, supported by sedentary and dietary lifestyle habits. In addition, rising indoor, industrial pollution, rapid
urbanization in developing countries and increasing greenhouse gas concentrations are expected to increase the
prevalence of pollen induced respiratory disorder, thereby boosting the overall market growth over the forecast
period.
Increasing incidences of allergies has triggered the demand for sensitive, cost effective and accurate diagnostics
tools. Manufacturers in congruence with the changing customer preferences are now engaged in constant product
development. For instance, the MeDALL allergen-chip for allergy determination is further expected to propel
market growth during the next seven years.
Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/allergy-diagnostic-market
Further key findings from the study suggest:

Consumables being an indispensable diagnostic product segment sell in large volumes and therefore,
dominated the market in 2014 with revenue share of over 55.0%. In addition, expensive nature of reagents
and their frequent application in diagnostic assay also supports the aforementioned fact.
Follow Us:

Increasing demand for analyzers and laminators for allergy diagnostics is expected to help this segment
grow at a lucrative CAGR of above 12.0% over the forecast period. Increasing awareness pertaining to
outsourcing of allergy testing services is anticipated to show upward shift in coming years.

Increasing demand for minimally invasive and allergen specific tests is anticipated to serve in vitro allergy
diagnostics market with future growth opportunities. The market is expected to grow with CAGR of above
12.0% over the forecast period.

Inhaled allergens accounted for the largest share of revenue in 2014 owing to, the growing incidences of
respiratory allergies. According to statistics published in 2012 by American Academy of Allergy Asthma and
Immunology (AAAAI), around 7.8 million children suffered from respiratory allergies worldwide and the
number is expected to increase over the forecast period.

Hospitals are the largest consumer of allergy diagnostic products. The segment is anticipated to grow with
CAGR of over 11.0% in coming years.

Antihistamines were the largest allergy therapeutic segment as of 2014 with share valued at over 17.0%
due to associated advantages such as non sedating nature of drugs and minimum side effects with use of
second generation antihistamines in allergy treatment.

Immunotherapy vaccines are expected to witness lucrative growth owing to extensive R&D coupled with
the introduction of sublingual immunotherapy tablets in the treatment of allergic rhinitis. For instance, In
April 2014, the U.S. FDA announced the approval of a five-grass pollen sublingual tablet (Ex-Oralair)
produced by Stallergenes which are used in the treatment of pollen allergy.

Some key players of this market include Thermo Fisher Scientific, Omega Diagnostics, Siemens Healthcare,
Stallergenes Greer, Lincoln Diagnostics, bioMerieux, HOB Biotech Group, Alcon Laboratories, Hycor
Biomedical and Hitachi Chemical Diagnostics.

Industry players are focusing on introducing technologically advanced and innovative products to gain
competitive advantage. For instance, in March 2015, Stallergenes received approval for STG 320 in Japan,
which is the first sublingual immunotherapy tablet used in the treatment of house dust mite allergy.
Grand View Research has segmented the allergy diagnostics and therapeutics market on the basis of product, enduse, diagnostic test, type of allergen, therapeutic class and region:
Global Allergy Diagnostics Product Outlook (Revenue, USD Million, 2012 - 2022)

Instruments

Consumables

Services
Global Allergy Diagnostics Allergen Type Outlook (Revenue, USD Million, 2012 - 2022)
Follow Us:

Food

Inhaled

Drug

Other
Global Allergy Diagnostics End-use Outlook (Revenue, USD Million, 2012 - 2022)

Diagnostic Laboratories

Hospitals

Academic Research Institutes
Global Allergy Diagnostics Test Outlook (Revenue, USD Million, 2012 - 2022)


In vivo test
o
Skin prick test
o
Intradermal test
o
Patch test
In vitro test
Global Allergy Therapeutics Drug Class Outlook (Revenue, USD Million, 2012 - 2022)

Antihistamines

Decongestants

Corticosteroids

Mast cell stabilizers

Leukotriene Inhibitors

Nasal anticholinergics

Immunomodulators

Autoinjectable Epinephrine

Immunotherapy
Allergy Diagnostics Regional Outlook (Revenue, USD Million, 2012 - 2022)
Follow Us:

North America
o



Europe
o
U.K
o
Germany
Asia Pacific
o
Japan
o
China
Latin America
o

U.S
Brazil
MEA
o
South Africa
Browse Related Category Reports @ https://www.grandviewresearch.com/industry/clinical-diagnostics
Follow Us:
Table of Content of Allergy Diagnostics And Therapeutics Market
Chapter 1 Methodology and Scope
1.1 Country wise market calculation
1.2 Region based segment share calculation
1.3 Primary Sources
1.4 List of secondary sources
Chapter 2 Executive Summary
Chapter 3 Allergy Diagnostics Industry Outlook
3.1 Market segmentation
3.2 Market size and growth prospects
3.3 Allergy Diagnostics: Market dynamics
3.3.1 Market driver analysis
3.3.1.1 Increasing incidences of allergy diseases
3.3.1.2 Increasing demand for IVD tests for allergy diagnosis
3.3.1.3 Introduction of technologically advance allergy diagnostics products
3.3.1.4 Growing healthcare expenditure triggering development of effective allergy diagnostic &
therapeutic products
3.3.2 Market restraint analysis
3.3.2.1 Low adoption and penetration in developing countries due to high cost of technology
3.3.2.2 Presence of ambiguous regulatory framework
3.4 Industry analysis - Porter’s
3.5 Key Opportunities Prioritized & Platform Positioning
3.5.1 Key Opportunities Prioritized
3.6 Allergy Diagnostics Competitive Landscape, 2014
3.6.1 Company Market Share Analysis, 2014
3.6.2 Competitive Landscape: Market Position Analysis
3.7 Pipleline Aanlysis: Allergy Therapeutics
3.8 Allergy Diagnostics- PESTEL analysis
Follow Us:
Chapter 4 Allergy Diagnostics Product Outlook
4.1 Allergy diagnostics market share, by product, 2014 & 2022
4.2 Instruments
4.2.1 Instruments market, 2012 - 2022 (USD Million)
4.3 Consumables
4.3.1 Consumables market, 2012 - 2022 (USD Million)
4.4 Services
4.4.1 Services market, 2012 - 2022 (USD Million)
Chapter 5 Allergy Diagnostics Allergen Type Outlook
5.1 Allergy diagnostics market share, by allergen type, 2014 & 2022
5.2 Food Allergen
5.2.1 Food Allergen market, 2012 - 2022 (USD Million)
5.3 Inhaled Allergen
5.3.1 Inhaled allergen market, 2012 - 2022 (USD Million)
5.4 Drug Allergen
5.4.1 Drug allergen market, 2012 - 2022 (USD Million)
5.5 Other
5.5.1 Other market, 2012 - 2022 (USD Million)
Chapter 6 Allergy Diagnostics End-use Outlook
6.1 Global allergy diagnostics market share, by end-use, 2014 & 2022
6.2 Academic Research Institutes
6.2.1 Academic research institutes market, 2012 - 2022 (USD Million)
6.3 Hospitals
6.3.1 Hospitals market, 2012 - 2022 (USD Million)
6.4 Diagnostic Laboratories
6.4.1 Diagnostic laboratories market, 2012 - 2022 (USD Million)
Chapter 7 Allergy Diagnostics Test Outlook
7.1 Global allergy diagnostics market share, by test, 2014 & 2022
Follow Us:
7.2 In vivo test
7.2.1 In vivo test market, 2012 - 2022 (USD Million)
7.2.2 Skin prick test
7.2.2.1 Skin prick test market, 2012 - 2022 (USD Million)
7.2.3 Intradermal test
7.2.3.1 Intradermal test market, 2012 - 2022 (USD Million)
7.2.4 Patch test
7.2.4.1 Patch test market, 2012 - 2022 (USD Million)
7.3 In vitro test
7.3.1 In vitro test market, 2012 - 2022 (USD Million)
Chapter 8 Allergy Therapeutics Drug Class Outlook
8.1 Global allergy therapeutics market share, by drug class, 2014 & 2022
8.2 Antihistamines
8.2.1 Antihistamines market, 2012 - 2022 (USD Million)
8.3 Corticosteroids
8.3.1 Corticosteroids market, 2012 - 2022 (USD Million)
8.4 Mast Cell Stabilizers
8.4.1 Mast Cell Stabilizers market, 2012 - 2022 (USD Million)
8.5 Leukotriene Inhibitors
8.5.1 Leukotriene Inhibitors market, 2012 - 2022 (USD Million)
8.6 Nasal anticholinergics
8.6.1 Nasal anticholinergics market, 2012 - 2022 (USD Million)
8.7 Decongestants
8.7.1 Decongestants market, 2012 - 2022 (USD Million)
8.8 Immunomodulators
8.8.1 Immunomodulators market, 2012 - 2022 (USD Million)
8.9 Autoinjectable Epinephrine
8.9.1 Autoinjectable epinephrine market, 2012 - 2022 (USD Million)
8.10 Immunotherapy
8.10.1 Immunotherapy market, 2012 - 2022 (USD Million)
Follow Us:
Chapter 9 Allergy Diagnostics Regional Outlook
9.1 Allergy Diagnostics market share, by region, 2014 & 2022
9.2 North America
9.2.1 North America allergy diagnostics market, 2012 - 2022 (USD Million)
9.2.2 North America allergy therapeutics market, 2012 - 2022 (USD Million)
9.2.3 U.S.
9.2.3.1 U.S. Allergy Diagnostics market, 2012 - 2022 (USD Million)
9.2.3.2 U.S. allergy therapeutics market, 2012 - 2022 (USD Million)
9.3 Europe
9.3.1 Europe Allergy Diagnostics market, 2012 - 2022 (USD Million)
9.3.2 Europe allergy therapeutics market, 2012 - 2022 (USD Million)
9.3.3 Germany
9.3.3.1 Germany Allergy Diagnostics market, 2012 - 2022 (USD Million)
9.3.3.2 Germany allergy therapeutics market, 2012 - 2022 (USD Million)
9.3.4 UK
9.3.4.1 UK allergy diagnostics market, 2012 - 2022 (USD Million)
9.3.4.2 UK allergy therapeutics market, 2012 - 2022 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific allergy diagnostics market, 2012 - 2022 (USD Million)
9.4.2 Asia Pacific allergy therapeutics market, 2012 - 2022 (USD Million)
9.4.3 Japan
9.4.3.1 Japan allergy diagnostics market, 2012 - 2022 (USD Million)
9.4.3.2 Japan allergy therapeutics market, 2012 - 2022 (USD Million)
9.4.4 China
9.4.4.1 China allergy diagnostics market, 2012 - 2022 (USD Million)
9.4.4.2 China allergy therapeutics market, 2012 - 2022 (USD Million)
9.5 Latin America
9.5.1 Latin America allergy diagnostics market, 2012 - 2022 (USD Million)
9.5.2 Latin America allergy therapeutics market, 2012 - 2022 (USD Million)
9.5.3 Brazil
Follow Us:
9.5.3.1 Brazil allergy diagnostics market, 2012 - 2022 (USD Million)
9.5.3.2 Brazil allergy therapeutics market, 2012 - 2022 (USD Million)
9.6 MEA
9.6.1 MEA allergy diagnostics market, 2012 - 2022 (USD Million)
9.6.2 MEA allergy therapeutics market, 2012 - 2022 (USD Million)
9.6.3 South Africa
9.6.3.1 South Africa allergy diagnostics market, 2012 - 2022 (USD Million)
9.6.3.2 South Africa allergy therapeutics market, 2012 - 2022 (USD Million)
Chapter 10 Competitive Landscape
10.1 bioMerieux
10.1.1 Company Overview
10.1.2 Financial Performance
10.1.3 Product Benchmarking
10.1.4 Strategic Initiatives
10.2 Danaher Corporation
10.2.1 Company Overview
10.2.2 Beckman Coulter
10.2.3 Financial Performance
10.2.4 Product Benchmarking
10.2.5 Strategic Initiatives
10.3 Thermo Fisher Scientific
10.3.1 Company Overview
10.3.2 Financial Performance
10.3.3 Product Benchmarking
10.3.4 Strategic Initiatives
10.4 Stallergenes Greer
10.4.1 Company Overview
10.4.2 Financial Performance
10.4.3 Product Benchmarking
10.4.4 Strategic Initiatives
Follow Us:
10.5 Hitachi Chemical Diagnostics
10.5.1 Company Overview
10.5.2 Financial Performance
10.5.3 Product Benchmarking
10.5.4 Strategic Initiatives
10.6 Siemens Healthcare
10.6.1 Company Overview
10.6.2 Financial Performance
10.6.3 Service Benchmarking
10.6.4 Strategic Initiatives
10.7 Omega Diagnostics
10.7.1 Company Overview
10.7.2 Financial Performance
10.7.3 Product Benchmarking
10.7.4 Strategic Initiatives
10.8 Hycor Biomedical
10.8.1 Company Overview
10.8.2 Financial Performance
10.8.3 Product Benchmarking
10.8.4 Strategic Initiatives
10.9 Lincoln Diagnostics
10.9.1 Company Overview
10.9.2 Financial Performance
10.9.3 Product Benchmarking
10.9.4 Strategic Initiatives
10.10 HOB Biotech Group
10.10.1 Company Overview
10.10.2 Financial Performance
10.10.3 Product Benchmarking
10.10.4 Strategic Initiatives
10.11 Alcon Laboratories, Inc.
Follow Us:
10.11.1 Company Overview
10.11.2 Financial Performance
10.11.3 Product Benchmarking
10.11.4 Strategic Initiatives
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed business decisions, the company offers
market intelligence studies ensuring relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
Follow Us:

Global allergy diagnostics and therapeutics market is expected to reach USD 40.8 billion by 2022, according to a new report by Grand View Research, Inc.

Download Report